Holte H - Search Results

1

Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.

Barzenje DA, Cvancarova Småstuen M, Liestøl K, Fosså A, Delabie J, Kolstad A, Holte H. Barzenje DA, et al. Among authors: holte h. PLoS One. 2015 Jul 6;10(7):e0131158. doi: 10.1371/journal.pone.0131158. eCollection 2015. PLoS One. 2015. PMID: 26147646 Free PMC article.

2

[High-dose therapy with autologous stem cell support in malignant lymphoma and breast cancer. Experiences with hematopoietic stem cells isolate from blood].

Kolstad A, Holte H, Kvaløy S, Jakobsen E, Erikstein B, Aurlien E, Kvalheim G, Bøhler PJ, Langholm R. Kolstad A, et al. Among authors: holte h. Tidsskr Nor Laegeforen. 1996 Sep 10;116(21):2547-51. Tidsskr Nor Laegeforen. 1996. PMID: 8928122 Norwegian.

3

Persistent changes in the immune system 4-10 years after ABMT.

Nordøy T, Kolstad A, Endresen P, Holte H, Kvaløy S, Kvalheim G, Husebekk A. Nordøy T, et al. Among authors: holte h. Bone Marrow Transplant. 1999 Oct;24(8):873-8. doi: 10.1038/sj.bmt.1702006. Bone Marrow Transplant. 1999. PMID: 10516699

4

Stage I high-grade non-Hodgkin's lymphoma.

Lote K, Holte H, Nome O, Langholm R, Kvaløy S. Lote K, et al. Among authors: holte h. Acta Oncol. 2000;39(7):865-72. doi: 10.1080/028418600750063631. Acta Oncol. 2000. PMID: 11145446

5

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.

Blystad AK, Enblad G, Kvaløy S, Berglund A, Delabie J, Holte H, Carlson K, Kvalheim G, Bengtsson M, Hagberg H. Blystad AK, et al. Among authors: holte h. Bone Marrow Transplant. 2001 Apr;27(7):711-6. doi: 10.1038/sj.bmt.1702867. Bone Marrow Transplant. 2001. PMID: 11360110

6

Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

Nordøy T, Husebekk A, Aaberge IS, Jenum PA, Samdal HH, Flugsrud LB, Kristoffersen AC, Holte H, Kvaløy S, Kolstad A. Nordøy T, et al. Among authors: holte h. Bone Marrow Transplant. 2001 Oct;28(7):681-7. doi: 10.1038/sj.bmt.1703228. Bone Marrow Transplant. 2001. PMID: 11704791

7

Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma.

Stokke T, DeAngelis P, Smedshammer L, Galteland E, Steen HB, Smeland EB, Delabie J, Holte H. Stokke T, et al. Among authors: holte h. Br J Cancer. 2001 Dec 14;85(12):1900-13. doi: 10.1054/bjoc.2001.2164. Br J Cancer. 2001. PMID: 11747333 Free PMC article.

8

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells.

Blystad AK, Holte H, Kvaløy S, Smeland E, Delabie J, Kvalheim G. Blystad AK, et al. Among authors: holte h. Bone Marrow Transplant. 2001 Nov;28(9):849-57. doi: 10.1038/sj.bmt.1703244. Bone Marrow Transplant. 2001. PMID: 11781645 Free PMC article.

9

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project. Rosenwald A, et al. Among authors: holte h. N Engl J Med. 2002 Jun 20;346(25):1937-47. doi: 10.1056/NEJMoa012914. N Engl J Med. 2002. PMID: 12075054 Free article.

10

M-FISH cytogenetic analysis of non-Hodgkin lymphomas with t(14;18)(q32;q21) and add(1)(p36) as a secondary abnormality shows that the extra material often comes from chromosome arm 17q.

Aamot H, Micci F, Holte H, Delabie J, Heim S. Aamot H, et al. Among authors: holte h. Leuk Lymphoma. 2002 May;43(5):1051-6. doi: 10.1080/10428190290021551. Leuk Lymphoma. 2002. PMID: 12148885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

287 results

Search Page